Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.
在肥胖的糖尿病前期或 2 型糖尿病患者中，与生活方式干预相比，利拉鲁肽可以降低体重减轻后可溶性 CD163 的水平
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-024-02237-8
Grannes Helene, Ueland Thor, Simeone Paola, Liani Rossella, Guagnano Maria Teresa, Aukrust PÃ¥l, Michelsen Annika E, Birkeland KÃ¥re, di Castelnuovo Augusto, Cipollone Francesco, Consoli Agostino, Halvorsen Bente, Gregersen Ida, Santilli Francesca
